The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure, Regardless of Diabetes Status: Focus on Cardiovascular Disease.

Filipe Ferrari,Vitor Magnus Martins,Rafael Selbach Scheffel,Anderson Donelli da Silveira,Marcelo Trotte Motta,Emílio Hideyuki Moriguchi,Raul D. Santos,Ricardo Stein

The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure, Regardless of Diabetes Status: Focus on Cardiovascular Disease.

2021

Filipe Ferrari
Vitor Magnus Martins
Rafael Selbach Scheffel
Anderson Donelli da Silveira
Marcelo Trotte Motta
Emílio Hideyuki Moriguchi
Raul D. Santos
Ricardo Stein

Objective:To provide clinical guidance and an overview of the available data on the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with heart failure with reduced ejection fra...

Keywords:

Disease
in patient
Sodium/Glucose Cotransporter 2
Internal medicine
Diabetes status
Medicine
Diabetes mellitus
Heart failure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations